Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Community pharmacy

Rowlands Pharmacy plans to reduce pharmacy network in order to 'invest in the future'

Kenny Black, managing director of Rowlands Pharmacy, said the company is selling 70 of its pharmacies to focus on “investing significantly” in automation across a “slightly smaller Rowlands pharmacy network”.

Rowlands Pharmacy has announced plans to sell 70 of its pharmacies — 69 in England and one in Wales — to focus its investment on automation.

In a statement issued on 21 February 2019, the pharmacy chain said that with the healthcare sector in the UK “evolving at pace”, there was a growing focus on locally-based preventative care — a core strength of community pharmacy.

As a result, Rowlands said it was “investing significantly” in automation through new central dispensing models to enable it to continue to provide high levels of service to patients in a more efficient way.

“We are committed to investing in the future and changing our dispensing processes in order to deliver sustainable, profitable growth for the business, enable colleagues to spend more time with patients and reinforce the role of Rowlands pharmacies as local healthcare hubs,” said Kenny Black, managing director of Rowlands Pharmacy.

“As a result, we need to focus our investment on a slightly smaller Rowlands pharmacy network than we have today.”

Black added that branch staff would be fully informed and supported throughout the process.

As of January 2019, Rowlands had 516 pharmacies registered with the General Pharmaceutical Council, making it the fourth largest pharmacy chain in the UK.

Simon Dukes, chief executive of the Pharmaceutical Services Negotiating Committee, said it came as “no surprise” that some of the larger pharmacy businesses were reviewing their networks and that the decision by Rowlands Pharmacy may be a symptom of the “very difficult” financial situation that many community pharmacies currently find themselves in.

“We know that the NHS and [the government] are looking to community pharmacies to offer more patient-focused services to support the delivery of their recently published vision for the delivery of primary healthcare,” he said.

“This will require transformative changes for the sector, including a shift away from the current focus on dispensing volumes; changes to working practices; and an increased focus on efficiencies, automation and technology to free up community pharmacists’ time to offer more clinical services.

Dukes also offered advice to individuals considering purchasing a new pharmacy and recommended that they seek specialist professional financial advice first.

“Like all pharmacy businesses, potential buyers should be thinking carefully about what changes their pharmacies are likely to need to make to fit into and remain profitable in the future models for the sector,” he said.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206206

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.